Live-attenuated measles/mumps vaccine (Wuhan Institute of Biological Products)

麻疹腮腺炎联合减毒活疫苗（武汉生物制品研究所）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLive-attenuated measles/mumps vaccine (Wuhan Institute of Biological Products)

Drug Alias Name武生思林Wu Sheng Si Lin

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Live attenuated vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II) +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsMumpsMeasles

Global Approved IndicationsMumpsMeasles

Approved Indications in ChinaMumpsMeasles

Original Approved Country/TerritoryMainland China

Original Approved Date2003/04/23

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesWuhan Institute Of Biological Products Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesWuhan Institute Of Biological Products Co Ltd

Inactive CompaniesN/A

Active IndicationsMumpsMeasles

Inactive IndicationsN/A

Other Information

ATC CodeJ07BD51